Stabiilsusuuringu, mida on soovinud Stabilise kasutajad

Viimane versioon :
06/08/2020

Stabiilsusuuringu, mida on soovinud Stabilise kasutajad : 42

Otsi uuringut

Molekulide nimekiri

Lahustite nimekiri

Pakendite nimekiri

Abiainete nimekiri

Ravimvormide nimekiri

Soovi kuupäev	Võtmesõnad	Aadress	Huvitatud uurimismeeskonnad	Avaldamise kuupäev
03/10/2017 Stability of SODIUM THIOSULFATE between 15 and 30mg/ml in 0.9% sodium chloride in polyolefine infusion bags over 24 hours. Surgeons want to administer sodium thiosulfate as a nephroprotector in the context of hyperthermic intraperitoneal chemotherapy (CHIP) with cisplatin.	Naatriumkloriid 0.9% Süsteravim Polüolefiin	Hospices Civils de Lyon - Groupement Hospitalier Sud - URCC RANCHON Florence 165 chemin du grand revoyet Pierre Benite FRANCE	Yes	02/10/2017
23/09/2017 Stability study of ETOPOSIDE at concentrations between 0.4 and 2 mg / ml diluted in 0.9% sodium chloride in polyolefin infusion bags over seven days. In order to counteract the shortage of etoposide phosphate (Etopophos®).	Etoposide Naatriumkloriid 0.9% Süsteravim Polüolefiin	University Hospital of Nancy D'Huart Elise Rue du Morvan Vandoeuvre France	Yes	23/09/2017
09/10/2017 The physicians of our hospital usually prescribe a mixture of PHLOROGLUCINOL 120 mg, METOCLOPRAMIDE 30 mg and TRIMEBUTINE 150 mg in 5% dextrose 1000 ml. We are looking for a stability study over 24 hours.	Metoclopramide hydrochloride; Phloroglucinol; Trimebutine Glükoos 5% Süsteravim	Hospital LA CHATRE BARBAIRE 40 rue des oiseaux La CHATRE (36400) FRANCE	No	09/10/2017
03/10/2017 Stability and degradation products in PARACETAMOL injections vials from BBraun®. Paracetamol injections from BBraun® show sometimes a pink colour. This colour change could be the consequence of a degradation product. The composition in excipient of the BBraun® formulation is: mannitol, citric acid and acetic acid. It could be interesting to have a stability study of this formulation.	Paracetamol Süsteravim Polüolefiin	CH VERDUN - Pharmacie COLLINOT BP 713 VERDUN France	No	02/10/2017
29/10/2017 Stability of CEFTAZIDIME/AVIBACTAM in Manufacturer’s Glass Vials. Ceftazidime/avibactam 2g/0,5g is reconstituted with 10ml of sterile water. The objectif of this study would be to determine the stability of reconstituted Ceftazidime/avibactam in glass vial over at least 48-hours to allow the reuse of the vial.	Ceftazidime Avibactam Süstevesi Süsteravim Klaas	Hôpitaux Universitaires de Strasbourg GILBERT 37 boulevard d'anvers Strasbourg France	Yes	17/11/2017
08/12/2017 Stability and compatibility of BUFFERED LIDOCAINE from 2.3mg/mL to 3.5 mg/mL with OCTREOTIDE from 2.8 mg/mL to 8.5 mg/mL to limit the pain associated with the intramuscular injection of octreotide.	Lidocaine hydrochloride; Octreotide acetate Süsteravim Süstal polüpropüleenist	CHU Angers - Pharmacie Briot 4 rue larrey Angers France	No	12/12/2017
12/01/2018 Stability study of PERTUZUMAB in polyolefin bags in 250 ml of Nacl 0.9%. Long shelf life would allow preparation in advance and potentially economic gain by using the end of flasks.	Pertuzumab Naatriumkloriid 0.9% Süsteravim Polüolefiin	Institut de Cancérologie de l'Ouest - Site Paul Papin Sorrieul jérémy 15 Rue Boquel Angers France	No	14/01/2018
19/01/2018 PEMBROLIZUMAB 25 mg/mL diluted in 0.9% chloride sodium at final concentration 4mg/mL. Storage 2-8°C. Stability up to 72 hours ? Manufacturer limits stability data in these conditions at 24 hours.	Pembrolizumab Naatriumkloriid 0.9% Süsteravim	CH René PLEVEN LEROUX CLAIRE 74 rue Chateaubriand - 22100 DINAN DINAN france	Yes	21/01/2018
29/01/2018 Stability study of ECULIZUMAB (Soliris®) 5 mg/mL in 0.9% sodium chloride, 0.45% sodium chloride or 5% glucose in polyolefin bags. Long shelf life would allow preparation in advance and would allow storing a bag for reassign it to another patient if the administration is canceled.	Eculizumab Naatriumkloriid 0.9%; Glükoos 5% Süsteravim Polüolefiin	UKC Ljubljana Martin Kastrin University Medical Centre Ljubljana, Zaloška 7, 1000 Ljubljana Ljubljana Slovenia	No	30/01/2018
30/01/2018 For Opioid Free Anesthesia : Stability in solution : 1. LIDOCAINE HYDROCHLORIDE 20 mg/mL diluted in 0.9% sodium chloride in polypropylene syringe, at 28°C. 2. KETAMINE HYDROCHLORIDE 2.5 mg/mL diluted in 0.9% sodium chloride in polypropylene syringe at 28°C. Stability of mixture : 1. Stability and compatibility LIDOCAINE HYDROCHLORIDE 20 mg/mL with KETAMINE HYDROCHLORIDE 2.5 mg/mL in 0.9% sodium chloride in polypropylene syringe. Compatibility: 1. Physical compatibility between DEXMEDETOMIDINE 4 µg/mL and KETAMINE 2.5 mg/mL.	Lidocaine hydrochloride; Ketamine hydrochloride; Dexmedetomidine Naatriumkloriid 0.9% Süsteravim Süstal polüpropüleenist	Réanimation Polyvalente et Centre de Traitement des Brûlés Hopital de Mercy CHR METZ-THIONVILLE Dr Damien BARRAUD 1, allée du château - cs 45001 57085 Metz - Cedex 03 France	Yes	02/03/2018
02/02/2018 Stability of NATALIZUMAB: a) opened vial (7days, 14 days, 1 month) b) prepared natalizumab in 100 ml NaCl piggy bag polyethylen (BAxter) (1day, 7 days, 14 days, 1 month)	Natalizumab Naatriumkloriid 0.9% Süsteravim Polüetüleen	General hospital Celje Jure Bracun Oblakova cesta 5a Celje Slovenia	No	02/02/2018
21/02/2018 Stability study of DINUTUXIMAB BETA solution. Concentrations : 0.05 mg/mL and 0.5 mg/mL in 100 mL 0.9% sodium chloride in polyolefin bags Duration : 72 hours These data would allow preparing in advance.		pharmacist UMCL Tina Benedejčič Zaloska 7 Ljubljana Slovenia	No	02/03/2018
03/05/2018 Stability study of a mixture : METOCLOPRAMIDE 0.04-0.12 mg/mL + NEOSTIGMINE 2-6µg/mL diluted in 250 ml NaCl 0,9% over 1-2 h.	Metoclopramide hydrochloride; Neostigmine methylsulfate Naatriumkloriid 0.9% Süsteravim	marienhospital stuttgart pharmacy reistle barbara böheimstr 37 Stuttgart Germany	No	07/05/2018
18/05/2018 Stability study : SUFENTANIL 0.01 mg/2mL with ROPIVACAIN HYDROCHLORIDE 2mg/mL 10mL and TRIAMCINOLON ACETONIDE 10 mg/mL suspension for injection. Administration : epidural injection Use : treatment of intervertebral disc damage	Sufentanil citrate; Ropivacain hydrochloride; Triamcinolone acetonide Süsteravim	LVR-Klinik Viersen Tobias Todeskino Horionstr. 2 41749 Viersen Deutschland	No	25/05/2018
07/06/2018 Stability Study of VEDOLIZUMAB in 250ml NaCl 0,9% Polyolefinbag over 72h, 7d, 14d. Storage 2-8°C	Vedolizumab Naatriumkloriid 0.9% Süsteravim Polüolefiin	Pharmacy Grillparzer Apotheke Einsteinstraße 127 81675 Munich Germany	No	11/06/2018
11/07/2018 Stability AFLIBERCEPT for intravitreal administration in prefilled syringes.	Aflibercept Süstal polüpropüleenist	Hospital Pharmacist Emilio Campos Dávila Hospital SAS La Línea. Servicio de Farmacia. c/Ronda Norte esquina Gabriel Miró 108. CP 11300. La Línea de la Concepción Spain	No	02/08/2018
03/09/2018 Stability studies : 1. PIPERACILLIN/TAZOBACTAM at 40mg/5mg/mL in dextrose 5% in polypropylene syringes. 2. GENTAMICIN SULFATE at 1 mg/mL in sodium chloride 0.9% in polypropylene syringes. 3. AMIKACIN SULFATE at 5 mg/mL in dextrose 5% in polypropylene syringes. 4. CAFFEINE CITRATE at 5 and 10 mg/mL in dextrose 5% in polypropylene syringes. 5. HEPARIN SODIUM at 0.5 Units/mL in sodium chloride 0.9% and in sodium chloride 0.45% in polypropylene syringes. 6. CEFTAZIDIME at 20mg/mL in dextrose 5% in polypropylene syringes.	Amikacin sulfate; Ceftazidime; Gentamicin sulfate; Heparin sodium; Piperacillin sodium / tazobactam; Caffeine citrate Naatriumkloriid 0.9%; Glükoos 5%; Naatriumkloriid 0.45% Süsteravim Süstal polüpropüleenist	NICU Pharmacist at Kaplan Medical Center Hospital Shay Teitlboim Loa Haary 45 Gedera ISRAEL	No	10/09/2018
05/09/2018 Stability studies of ACICLOVIR SODIUM at - 5 mg/mL in sodium chloride 0.9% in polypropylene syringes. - at different concentrations up to 5 mg/mL in polyolefin bags.	Aciclovir sodium Naatriumkloriid 0.9% Süsteravim Polüolefiin; Süstal polüpropüleenist	Lead Pharmacist Aseptic Services Russell Dodd University Hospitals of Morecambe Bay NHS Trust Lancaster England, United Kingdom	No	10/09/2018
17/09/2018 Stability study for intraocular use: VANCOMYCIN 2 mg/mL and 10 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.	Vancomycin hydrochloride BSS solution® Süsteravim Süstal polüpropüleenist	St John of God Hospital Subiaco Michelle Fall 12 Salvado Rd Subiaco Australia	No	24/09/2018
24/09/2018 Stability study for intraocular use: AMIKACIN 4 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.	Amikacin sulfate BSS solution® Silmatilgad Süstal polüpropüleenist	St John of God Hospital Subiaco Michelle Fall 12 Salvado Rd Subiaco Australia	No	24/09/2018
21/09/2018 Stability studies : VEDOLIZUMAB, TOCILIZUMAB, ABATACEPT, PEMBROLIZUMAB.	Vedolizumab; Pembrolizumab Süsteravim Polüolefiin	HOPITAUX PRIVES DE METZ PONSEELE MAGDALENA 2 RUE BELLE ISLE METZ FRANCE	No	24/09/2018
24/09/2018 Stability study for intraocular use: GENTAMICIN 0.8 mg/mL and 1 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.	Gentamicin sulfate BSS solution® Süstal polüpropüleenist	St John of God Hospital Subiaco Michelle Fall 12 Salvado Rd Subiaco Australia	No	24/09/2018
24/09/2018 Stability study for intraocular use: CEFTAZIDIME 22.5 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.	Ceftazidime BSS solution® Silmatilgad Süstal polüpropüleenist	St John of God Hospital Subiaco Michelle Fall 12 Salvado Rd Subiaco Australia	No	24/09/2018
24/09/2018 Stability study for intraocular use: VORICONAZOLE 1 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.	Voriconazole BSS solution® Silmatilgad Süstal polüpropüleenist	St John of God Hospital Subiaco Michelle Fall 12 Salvado Rd Subiaco Australia	No	24/09/2018
24/09/2018 Stability study for intraocular use: AMPHOTERICIN 0.05 mg/mL in balanced salt solution (BSS solution®) in polypropylene syringe.	Amphotericin B BSS solution® Silmatilgad Süstal polüpropüleenist	St John of God Hospital Subiaco Michelle Fall 12 Salvado Rd Subiaco Australia	No	24/09/2018
21/11/2018 Stability studies on : - DARATUMUMAB infusions at concentrations between 0.5 and 4 mg/mL, diluted in NaCl 0.9%, in polyolefin bags. - DARATUMUMAB subcutaneous 1800 mg, in polypropylene syringes.	Daratumumab Naatriumkloriid 0.9% Süsteravim Polüolefiin; Süstal polüpropüleenist	CHRU Nancy Lider Pauline CHRU Nancy - Hôpital Brabois Adultes - Service Pharmacie - 5 rue du Morvan Vandoeuvre-lès-Nancy France	No	26/11/2018
04/12/2018 Stability study of OCTREOTIDE at 3.75 µg/mL in elastomer( 900 µg in 240 mL of 0.9% sodium chloride). Indication : occlusion on peritoneal carcinomatosis.	Octreotide acetate Naatriumkloriid 0.9% Süsteravim Elastomeer	GH Diaconesses Croix saint simon Capucine Devaux 125 rue avron paris France	No	11/12/2018
21/01/2019 Stability study on PEMBROLIZUMAB at 2 mg/mL diluted in 0.9%NaCl in polyolefin bag for 1 month.	Pembrolizumab Naatriumkloriid 0.9% Süsteravim Polüolefiin	CHU DIJON PERNOT Corinne 14 rue gaffarel 21000 DIJON DIJON FRANCE	No	06/02/2019
21/01/2019 Stability study on DARATUMUMAB infusion between 0.5 and 4mg/mL in 0.9% NaCl, in polyolefin bag.	Daratumumab Naatriumkloriid 0.9% Süsteravim Polüolefiin	CHU DIJON PERNOT Corinne 14 rue gaffarel 21000 DIJON DIJON FRANCE	No	04/02/2019
11/03/2019 Stability studies of CYTARABINE : - after dilution in 5 % dextrose, 0.9% sodium chloride or glucose with sodium chloride. - for the unused vial after reconstitution.	Cytarabine Naatriumkloriid 0.9%; Glükoos 5% Süsteravim Klaas; Polüolefiin	Solvent Dr Hussein 1st abd elhamid barakat BAHEST EL badayiah CORNICHE EL NILE EL SAHEL Cairo Egypt Cairo Egypt	No	01/04/2019
27/03/2019 Stability study of : - METHOTREXATE at 1.5 mg/mL - CYTARABINE at 3.75 mg/mL - HYDROCORTISONE HEMISUCCINATE at 2.5 mg/mL for spinal injection.	Cytarabine; Methotrexate sodium; Hydrocortisone sodium succinate Süsteravim Süstal polüpropüleenist	Centre hospitalier d'Arras DANOS 3 Boulevard Besnier 62022 Arras Cedex France	No	01/04/2019
28/06/2019 Stability study of a mixture levofolinate disodium and fluorouracil in 0.9% sodium chloride infusion bags ( 100 mL)	Fluorouracil; Levofolinate disodium Naatriumkloriid 0.9%	Polyclinique de Gentilly Alfonsi 2, rue Marie Marvingt NANCY France	No	10/07/2019
02/07/2019 Compatibility tests between drugs and balanced infusions solutions as Ringer-acetat.		Pharmacist at a regional drug inforamtion centre in Norway Terje Nilsen Sykehusveien 20 Tromsø Norway	No	10/07/2019
30/09/2019 Stability of CEFTAZIDIME/AVIBACTAM (ZAVICEFTA or AVYCAZ) in elastomeric pumps.	Ceftazidime Avibactam Süsteravim Elastomeer	Uppsala university hospital Mattias Paulsson Entrance 13 Uppsala Sweden	Yes	03/10/2019
06/03/2020 Stability study of a mixture : METAMIZOLE + TRAMADOL + DIMENHYDRATE in 0.9 % sodium chloride.	Tramadol hydrochloride; Dimenhydrinate; Metamizol sodium Naatriumkloriid 0.9% Süsteravim	nn Anneke Maiworm Apotheke des Universitätsklinikums Düsseldorf Düsseldorf Deutschland	No	23/03/2020
22/11/2019 Stability of morphine HCl (2mg/ml) + DHB (0.08mg/ml) + NaCl 0.9% syringe Stability of morphine HCl (2mg/ml) + ketamine (3.3 mg/ml) + NaCl 0.9% syringe Stability of piritramide 2 mg/ml + NaCl 0.9% syringe	Droperidol; Morphine hydrochloride; Ketamine hydrochloride; Piritramide Naatriumkloriid 0.9% Süsteravim Süstal polüpropüleenist	Clinique Saint Luc bouge Anrys Rue Saint-Luc, 1 Bouge Belgique	No	06/12/2019
11/11/2019 Stability of Clarithromycin 1% for eye drops.	Silmatilgad	Pharmacist Julia Parts Spitalstrasse Luzern Schweiz	No	06/12/2019
24/10/2019 Stability study of ARSENIC TRIOXIDE at concentrations between 0.2 and 0.1 mg/mL diluted in 0.9% sodium chloride or 5% dextrose, in polyolefine or PVC infusion bags over five days.	Arsenic trioxyde Naatriumkloriid 0.9%; Glükoos 5% Süsteravim Polüvinüülkloriid; Polüolefiin	Hosp Pediatrico Humberto Notti Hector Cruceño Bandera de los Andes 2601 San Jose Argentina	No	06/11/2019
07/02/2020 Stability study of a mixture : morphine, droperidol and ketamine.	Droperidol; Morphine hydrochloride; Ketamine hydrochloride Süsteravim	CH PIERRE OUDOT PONT 38300 BOURGOIN JALLIEU FRANCE	No	26/02/2020
08/05/2020 Stability studies for oral solutions of : - morphine hydrochloride [0.4-1 mg/mL] - methadone hydrochloride [0.4-1 mg/mL]	Suukaudne lahus	CENTRE HOSPITALIER LUXEMBOURG ISABELLE LAROSCHE 4 RUE BARBLE 1210 Luxemnbourg LUXEMBOURG	No	15/05/2020
28/05/2020 Stability study of PEMBROLIZUMAB	Pembrolizumab	CH François Quesnay KANE 02 Boulevard Sully Mantes La Jolie (78200) FRANCE	No	30/05/2020
29/06/2020 Stability study of doxycycline eye drops at 2.5 and 0.25%.	Doxycycline hyclate Silmatilgad Klaas	Pharmacie laboratoire preparation magistrale Von roten 1926 Fully Suisse	No	26/07/2020

Mentions Légales